Cellex recalls Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
- Recall date
- March 1, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2452-2021
- FDA classification
- Class II
- Brand / firm
- Cellex
- Sold / distributed
- US Nationwide distribution in the states of CA, FL, TX, and WI.
Why it was recalled
The kit does not have an emergency use authorization (EUA).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
Get recall alerts
Free email alert whenever Cellex has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cellex